Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program

BACKGROUND: Inhibitors of poly-ADP ribose polymerase (PARP), an enzyme involved in base excision repair (BER) have demonstrated single agent activity against tumors deficient in homologous repair processes. Ewing sarcoma cells are also sensitive to PARP inhibitors, although the mechanism is not unde...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Smith, Malcolm A., Reynolds, Patrick, Kang, Min H., Kolb, E. Anders, Gorlick, Richard, Carol, C. Hernan, Lock, Richard B., Keir, Stephen T., Maris, John M., Billups, Catherine A., Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587665/
https://ncbi.nlm.nih.gov/pubmed/25500058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2572
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky